Kerry Holford
Stock Analyst at Berenberg Bank
(3.93)
# 1,826
Out of 5,020 analysts
198
Total ratings
57%
Success rate
8.4%
Average return
Main Sectors:
Stocks Rated by Kerry Holford
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: GSK GSK plc | Reiterated: Hold | 2,000p → 2,200p | 1,795p | +22.56% | 51 | Sep 15, 2026 | |
| LLY Eli Lilly and Company | Upgraded: Buy | $1,220 → $1,400 | $1,149.85 | +21.76% | 33 | Sep 14, 2026 | |
| SWX: NOVN Novartis AG | Reiterated: Hold | CHF 120.00 → CHF 105.00 | CHF 118.06 | -11.06% | 42 | Sep 11, 2026 | |
| NVO Novo Nordisk | Downgraded: Hold | $47 | $37.40 | +25.67% | 8 | Aug 11, 2026 | |
| PFE Pfizer | Reiterated: Hold | $25 | $28.12 | -11.10% | 31 | Aug 5, 2026 | |
| NVS Novartis AG | Reiterated: Hold | $141 → $147 | $141.05 | +4.22% | 9 | Jul 27, 2026 | |
| GSK GSK plc | Reiterated: Hold | $41 → $43 | $47.18 | -8.86% | 14 | Nov 25, 2025 | |
| EPA: SAN Sanofi | Reiterated: Buy | €105.00 → €120.00 | €73.10 | n/a | 3 | May 16, 2025 | |
| EPA: EFG Eagle Football Group SA | Reiterated: Hold | €1.60 | €1.64 | n/a | 2 | Apr 1, 2025 | |
| EL The Estée Lauder Companies | Reiterated: Hold | $65 → $60 | $90.19 | n/a | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 100p | 39p | n/a | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €150.00 | €134.45 | n/a | 1 | Apr 16, 2021 |
GSK plc
Sep 15, 2026
Reiterated: Hold
Price Target: 2,000p → 2,200p
Current: 1,795p
Upside: +22.56%
Eli Lilly and Company
Sep 14, 2026
Upgraded: Buy
Price Target: $1,220 → $1,400
Current: $1,149.85
Upside: +21.76%
Novartis AG
Sep 11, 2026
Reiterated: Hold
Price Target: CHF 120.00 → CHF 105.00
Current: CHF 118.06
Upside: -11.06%
Novo Nordisk
Aug 11, 2026
Downgraded: Hold
Price Target: $47
Current: $37.40
Upside: +25.67%
Pfizer
Aug 5, 2026
Reiterated: Hold
Price Target: $25
Current: $28.12
Upside: -11.10%
Novartis AG
Jul 27, 2026
Reiterated: Hold
Price Target: $141 → $147
Current: $141.05
Upside: +4.22%
GSK plc
Nov 25, 2025
Reiterated: Hold
Price Target: $41 → $43
Current: $47.18
Upside: -8.86%
Sanofi
May 16, 2025
Reiterated: Buy
Price Target: €105.00 → €120.00
Current: €73.10
Upside: n/a
Eagle Football Group SA
Apr 1, 2025
Reiterated: Hold
Price Target: €1.60
Current: €1.64
Upside: n/a
The Estée Lauder Companies
Mar 24, 2025
Reiterated: Hold
Price Target: $65 → $60
Current: $90.19
Upside: n/a
Mar 24, 2025
Reiterated: Buy
Price Target: 100p
Current: 39p
Upside: n/a
Apr 16, 2021
Reiterated: Hold
Price Target: €150.00
Current: €134.45
Upside: n/a